Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Alice Wiedeman

9PUBLICATIONS
48CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursTransplantation immunologyMedical biochemistry - proteins and peptides (incl. medical proteomics)Neonatology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

Sort by Publication Date:
|Mar 12, 2025
Early expansion of TIGIT+PD1+ effector memory CD4 T cells via agonistic effect of alefacept in new-onset type 1 diabetes.

Lauren E Higdon, Laura A Cooney, Elisavet Serti

|Jun 27, 2024
Interconnected lineage trajectories link conventional and natural killer (NK)-like exhausted CD8<sup>+</sup> T cells beneficial in type 1 diabetes.

Erin M Witkop, Kirsten Diggins, Alice Wiedeman

|May 08, 2024
A phase 2 randomized trial with autologous polyclonal expanded regulatory T cells in children with new-onset type 1 diabetes.

Christine Bender, Alice E Wiedeman, Alex Hu

|May 02, 2024
Impact on in-depth immunophenotyping of delay to peripheral blood processing.

Lauren E Higdon, Sheila Scheiding, Anna M Kus

|Oct 02, 2023
A first-in-human, open-label Phase 1b and a randomised, double-blind Phase 2a clinical trial in recent-onset type 1 diabetes with AG019 as monotherapy and in combination with teplizumab.

Chantal Mathieu, Alice Wiedeman, Karen Cerosaletti

|Nov 23, 2022
Inflammatory bone marrow signaling in pediatric acute myeloid leukemia distinguishes patients with poor outcomes.

Hamid Bolouri, Rhonda E Ries, Alice E Wiedeman

Pageof 2

Frequent Collaborators

9 joint publications

Sarah Alice Long

4 joint publications

Cate Speake

4 joint publications

Vivian H Gersuk

3 joint publications

Elisavet Serti

3 joint publications

Sheila Scheiding

3 joint publications

Peter S Linsley

2 joint publications

Kevan C Herold

2 joint publications

Lauren E Higdon

2 joint publications

Jane H Buckner

2 joint publications

Alex Hu

Frequent Collaborators

9 joint publications

Sarah Alice Long

4 joint publications

Cate Speake

4 joint publications

Vivian H Gersuk

3 joint publications

Elisavet Serti

Top Related Videos

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on : May 06, 2013

16.7K
Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
16:26

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on : Aug 20, 2007

5.8K
See more related videos

Top Related Videos

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on : May 06, 2013

16.7K
Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
16:26

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on : Aug 20, 2007

5.8K
See more related videos